Publications
Publications
- April 2004 (Revised May 2007)
- HBS Case Collection
Conor Medsystems
By: Donald N. Sull, Robert F. Higgins, Linda A. Cyr and Bijan Salehizadeh
Abstract
Conor Medsystems had developed a drug-eluting stent that could capture significant share of the $5 billion global market. Chief executive officer, Frank Litvack, is considering alternative sources of financing to test the device.
Keywords
Entrepreneurship; Health Testing and Trials; Corporate Finance; Medical Devices and Supplies Industry
Citation
Sull, Donald N., Robert F. Higgins, Linda A. Cyr, and Bijan Salehizadeh. "Conor Medsystems." Harvard Business School Case 804-180, April 2004. (Revised May 2007.)